Spero Therapeutics, Inc 10-K for FY2025
Spero Therapeutics, Inc. (SPRO)
10-K
2026-03-26
For: 2025-12-31
View Original
Added on
April 07, 2026
About this 10-K
Spero Therapeutics, Inc filed this 10-K on March 26, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $66.8M
- up 39.2% from $47.98M a year earlier
- Net income
- $8.57M
- compared with a net loss of $68.57M a year earlier
- Diluted EPS
- $0.15
- compared with -$1.27 a year earlier